Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Aminocaproic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLG known ✓ | P00747 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 4/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | THRB | P10828 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 2/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.48 |
| ▸ | GABRP | O00591 | 1/20 | 0.48 |
| ▸ | GABRD | O14764 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.48 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octanedioate SCHEMBL1394807 | 0.91 | TSHR (0.52) | LMNAKMT2AMEN1ALDH1A1ALOX15 | |
| Azelaic Acid SCHEMBL28918234 | 0.91 | TSHR (0.52) | LMNAKMT2AMEN1ALDH1A1ALOX15 | |
| Sebacic Acid SCHEMBL28228671 | 0.91 | TSHR (0.52) | LMNAKMT2AMEN1ALDH1A1ALOX15 | |
| Octanedioate SCHEMBL6037661 | 0.91 | TSHR (0.52) | LMNAKMT2AMEN1ALDH1A1ALOX15 | |
| Adipic Acid SCHEMBL29427201 | 0.89 | LMNA (0.50) | LMNAKMT2AMEN1ALDH1A1NFKB1 | |
| Adipic Acid SCHEMBL906129 | 0.89 | LMNA (0.50) | LMNAKMT2AMEN1ALDH1A1NFKB1 | |
| Sebacic Acid SCHEMBL29286911 | 0.85 | GPR84 (0.50) | LMNAKMT2AMEN1ALDH1A1ALOX15 | |
| Glutarate SCHEMBL9485824 | 0.85 | SLC22A6 (0.50) | LMNAKMT2ATHRBMEN1NFKB1 | |
| Glutarate SCHEMBL28487046 | 0.85 | SLC22A6 (0.50) | LMNAKMT2ATHRBMEN1NFKB1 | |
| SCHEMBL9576050 | 0.82 | TSHR (0.43) | LMNAKMT2AMEN1ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5998616-A | Biocatalyst for the conversion of carbonyl compounds to their β-unsaturated derivatives using molecular oxygen as the oxidant | THE UNIVERSITY OF MICHIGAN (US) | 1999-12-07 | — | — | US | claimed |
| US-20180217158-A1 | METHODS FOR DETECTING ANTI-HE4 ANTIBODIES AND METHODS OF DIAGNOSIS AND/OR PROGNOSIS OF CONDITIONS ASSOCIATED WITH HE4-EXPRESSING CELLS | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2018-08-02 | — | — | US | disclosed |
| EP-2609429-B1 | METHODS FOR DETECTING ANTI-HE4 ANTIBODIES AND METHODS OF DIAGNOSIS AND/OR PROGNOSIS OF CONDITIONS ASSOCIATED WITH HE4-EXPRESSING CELLS | UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2017-09-20 | — | — | EP | disclosed |
| US-20130224772-A1 | METHOD FOR DETECTING ANTI-HE4 ANTIBODIES AND METHODS OF DIAGNOSIS AND/OR PROGNOSIS OF CONDITIONS ASSOCIATED WITH HE4-EXPRESSING CELLS | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2013-08-29 | — | — | US | disclosed |
| EP-2609429-A2 | METHODS FOR DETECTING ANTI-HE4 ANTIBODIES AND METHODS OF DIAGNOSIS AND/OR PROGNOSIS OF CONDITIONS ASSOCIATED WITH HE4-EXPRESSING CELLS | University Of Washington Through Its Center For Commercialization (US) | 2013-07-03 | — | — | EP | disclosed |
| WO-2012027631-A2 | METHODS FOR DETECTING ANTI-HE4 ANTIBODIES AND METHODS OF DIAGNOSIS AND/OR PROGNOSIS OF CONDITIONS ASSOCIATED WITH HE4-EXPRESSING CELLS | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2012-03-01 | — | — | WO | disclosed |
| WO-2010053115-A1 | NOVEL AFFINITY SUPPORT | 大日本住友製薬株式会社 (JP) | 2010-05-14 | — | — | WO | disclosed |
| US-6046043-A | REGIO- AND STEREOSELECTIVELY OXIDIZING SATURATED ALDEHYDES, KETONES, ESTERS OR AMIDES USING A COMPLEX OF APOFLAVOPROTEIN AND A DERIVATIVE OF FLAVINMONONUCLEOTIDE TO THEIR UNSATURATED DERVIATIVES UNDER MILD CONDITONS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2000-04-04 | — | — | US | disclosed |
| US-5998616-A | Biocatalyst for the conversion of carbonyl compounds to their β-unsaturated derivatives using molecular oxygen as the oxidant | THE UNIVERSITY OF MICHIGAN (US) | 1999-12-07 | — | — | US | disclosed |